Altimmune Inc (NASDAQ:ALT)

4.87
Delayed Data
As of 3:59pm ET
 +0.25 / +5.41%
Today’s Change
3.83
Today|||52-Week Range
19.46
-46.83%
Year-to-Date

Today’s Trading

Previous close4.62
Today’s open4.62
Day’s range4.62 - 4.94
Volume38,815
Average volume (3 months)807,446
Market cap$206.2M
Data as of 3:59pm ET, 05/26/2022

Growth & Valuation

Earnings growth (last year)-22.94%
Earnings growth (this year)+4.32%
Earnings growth (next 5 years)--
Revenue growth (last year)-46.12%
P/E ratioNM
Price/Sales85.74
Price/Book1.04

Competitors

 Today’s
change
Today’s
% change
KMDAKamada Ltd+0.08+1.90%
JNCEJounce Therapeutics ...+0.08+2.19%
XOMAXOMA Corp+0.84+4.89%
LCTXLineage Cell Therape...+0.04+3.28%
Data as of 4:00pm ET, 05/26/2022

Financials

Next reporting dateAugust 16, 2022
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$4.4M
Annual profit (last year)-$97.1M
Net profit margin-2,201.43%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts